Sarepta was valued closeto $1 BILLION after positive phase 2 results and this pure goldmine here still trading at laughable US$ 27 million ..A LIFETIME OPP HERE ...Diamond should list the company on Nasdaq asap and we would quickly see the share price moving closer to $3 . But i still think that buyout will happen in the short term because ANP is more than a pure gift at this price -
Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-424
-
- There are more pages in this discussion • 172 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
